Mayo Clinic Laboratories’ robust portfolio of clinically supported assays to test for marijuana use is consistent with professional recommendations.
Whole exome sequencing for hereditary disorders - Insights
Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small...
New tests launched in August - Insights
In August 2022, Mayo Clinic Laboratories announced thirty-two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Therapeutics events - Insights
TherapeuticS Creating the new standard of therapeutic management, together Mayo Clinic Laboratories’ evidence-based toxicology and pharmacogenomic testing
2025 International Conference - Insights
For more than 40 years, this meeting has been the major international conference in Lyme disease and other tick-borne infections, bringing together the most knowledgeable investigators in the world and their trainees to share scientific...
2025 International Conference - Insights
For more than 40 years, this meeting has been the major international conference in Lyme disease and other tick-borne infections, bringing together the most knowledgeable investigators in the world and their trainees to share scientific...
2025 International Conference - Insights
For more than 40 years, this meeting has been the major international conference in Lyme disease and other tick-borne infections, bringing together the most knowledgeable investigators in the world and their trainees to share scientific...
2025 International Conference - Insights
For more than 40 years, this meeting has been the major international conference in Lyme disease and other tick-borne infections, bringing together the most knowledgeable investigators in the world and their trainees to share scientific...
Linda Hasadsri, M.D., Ph.D., explains carrier screening at Mayo Clinic Laboratories. Using targeted genotyping, our three focused panels evaluate genes associated with cystic fibrosis, spinal muscular atrophy, and hemoglobinopathies, to...
2025 International Conference - Insights
For more than 40 years, this meeting has been the major international conference in Lyme disease and other tick-borne infections, bringing together the most knowledgeable investigators in the world and their trainees to share scientific...